2α, 3α-Epithio-5α-androstan-17β-YL 1-methoxycyclopentyl ether in the treatment of advanced breast cancer

Publisher Website

1 February 1978

journal article
research article
Published by Wiley in Cancer

Vol. 41 (2) , 758-760
https://doi.org/10.1002/1097-0142(197802)41:2<758::aid-cncr2820410249>3.0.co;2-u

Abstract

No abstract available

Keywords

This publication has 4 references indexed in Scilit:

2α,3α-Epithio-5α-androstan-17β-yl 1-methoxycyclopentyl ether (10364-s), a new orally active anti-estrogenic steroid
Steroids, 1974
2α, 3α-Epithio-5α-Androstan-17β-yl 1-Methoxy Cyclopentyl Ether (10364-S), A New Orally Active Anabolic-Androgenic Steroid
The Japanese Journal of Pharmacology, 1974
2α,3α-epithio-5α-androstan-17β-ol in the treatment of advanced breast cancer. Japanese cooperative group of hormonal treatment for breast cancer
Cancer, 1973
Testosterone Propionate Therapy in Breast Cancer
JAMA, 1964